These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing||2004-000330-36||Phase 3 Randomized Study of TLK286 (Telcyta?) versus Gefitinib (Iressa®) as Third-Line Therapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer||not-yet-due|
|Not reported||2006-000366-36||Phase 3 randomized study of TLK286 (Telcyta™) in combination with liposomal doxorubicin (Doxil®/Caelyx®) versus liposomal doxorubicin (Doxil®/Caelyx®) as second-line therapy in platinum refractory or ...||2008-06-30||due-trials|